期刊文献+

儿童红细胞增多症的诊断思路与治疗进展 被引量:5

Diagnostic thought and progress of treatment of erythrocytosis in children
原文传递
导出
摘要 红细胞增多症(erythrocytosis)以红细胞数目、血红蛋白及血细胞比容显著超过正常水平为特点。红细胞增多症多见于成人,且多为真性红细胞增多症,而在儿童病例中继发性红细胞增多症或由基因突变引起的先天性红细胞增多症更为常见。近些年,红细胞增多症的诊断和治疗有了新的进展,现对儿童红细胞增多症的病因、诊断及治疗进展等相关问题进行综述,进一步丰富儿科医师对红细胞增多症的诊断与治疗思路。 Erythrocytosis is characterized by an obvious increase in the erythrocyte count, the hematocrit and the hemoglobin content above reference range.Erythrocytosis is more common in adults, and is mostly polycythemia vera, but in children secondary erythrocytosis or congenital erythrocytosis caused by genetic mutations is more common.In recent years, the diagnosis and treatment of erythrocytosis have made new progress, now by the explanation of etiology, diagnosis and treatment progress of erythrocytosis, the aim of the thesis is to further enrich the knowledges of pe-diatricians about the diagnosis and treatment of erythrocytosis.
作者 孙君杰 刘爱国 Sun Junjie;Liu Aiguo(Department of Pediatrics,Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2018年第15期1194-1197,共4页 Chinese Journal of Applied Clinical Pediatrics
关键词 红细胞增多症 病因 诊断 治疗 儿童 Erythrocytosis Etiology Diagnosis Treatment Child
作者简介 通信作者:刘爱国,Email:drliuaiguo@163.com
  • 相关文献

参考文献4

二级参考文献53

  • 1Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasmsand acute leukemia [J]. Blood, 2016, 127 (20):2391-2405. doi: 10.1182/blood-2016-03 -643544.
  • 2Moulard O, Mehta J, Fryzek J, et al. Epidemiology of myelofi- brosis, essential thrombocythemia, and polycythemia vera in the European Union[J]. Eur J Haematol, 2014, 92(4):289-297. doi: 10.1111/ejh.12256.
  • 3Tefferi A, Guglielmelli P, Larson DR, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis [J]. Blood, 2014, 124(16):2507-2513. doi:10.1182/blood-2014-05- 579136.
  • 4Barbui T, Thiele J, Vannucchi AM, et al. Rethinking the diagnos- tic criteria of polycythemia vera [J]. Leukemia, 2014, 28 (6): 1191-1195. doi: 10.1038/leu.2013.380.
  • 5Silver RT, Chow W, Orazi A, et al. Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis [J]. Blood, 2013, 122 ( 11 ):1881-1886. doi: 10.1182/blood-2013-06- 508416.
  • 6Barbui T, Thiele J, Carobbio A, et al. Masked polycythemia vera diagnosed according to WHO and BCSH classification [J]. Am J Hematol, 2014, 89(2):199-202. doi:10.1002/ajh.23617.
  • 7Lussana F, Carobbio A, Randi ML, et al. A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera [J]. Br J Haematol, 2014, 167(4):541-546. doi: 10.1111/bjh. 13080.
  • 8Barbui T, Thiele J, Carobbio A, et al. Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients [J]. Am J Hematol, 2014, 89 (6):588- 590. doi: 10.1002/ajh.23694.
  • 9Barbui T, Thiele J, Passamonti F, et al. Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome [J]. Blood, 2012, 119:2239-2241. doi: 10.1182/ blood-2011-11393819.
  • 10Thiele J, Kvasnicka HM, Zankovich R, et al. The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemias [J]. Haematologica, 2001, 86(4) :368-374.

共引文献31

同被引文献33

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部